Is Moderna Stock A Sell After The Company Slashed Its Sales Guide, R&D Budget? Is Moderna Stock A Sell After The Company Slashed Its Sales Guide, R&D Budget? · Investor's Business Daily ALLISON GATLIN Fri, Sep 13, 2024, 5:01 AM 4 min read In This Article: MRNA Moderna stock tumbled after the company cut its 2024 sales outlook and 2027 R&D budget. Is MRNA stock now a sell? Continue Reading View Comments Terms and Privacy Policy WA Consumer Health Privacy Policy Your privacy controls Recommended Stories